Skip to content

SCHEDULE 13DAccepted Aug 18, 5:41 PM ET

BridgeBio Oncology Therapeutics, Inc. SCHEDULE 13D

BridgeBio Pharma LLC

Accepted (ET)

5:41 PM

Aug 18, 2025

Filed

Aug 18, 2025

Documents

3

Size

61.1 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.